4 unknown. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 1 | 1 | Unknown 1 |
Follow CHOP: new trials by email Literature Review of CHOP trials Research Report on CHOP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCL Parsaclisib, CHOP - PI3Kδ Inhibitor, Parsaclisib | Phase 1 / Phase 2 | Unknown | Fudan University | 30 | 2022-03-01 | 2022-02-14 |
| Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma CHOP, CHOP+X - Peripheral T-cell Lymphoma | Phase 2 | Unknown | Ruijin Hospital | 96 | 2020-07-29 | 2023-06-13 |
| Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL CHOP, fractionated ICED - Peripheral T-cell Lymphoma | Phase 2 | Unknown | Samsung Medical Center | 134 | 2015-09-23 | 2020-10-22 |
| Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma Immunochemotherapy, High-dose BEAM plus autologous SCT, HLA-identical allogenic SCT - Mantle-Cell Lymphoma | Phase 2 | Unknown | Heidelberg University | 20 | 2004-07-01 | 2009-07-27 |
Lymphoma, T-Cell, Peripheral (2) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1)
Fudan University (1) · Heidelberg University (1) · Ruijin Hospital (1) · Samsung Medical Center (1)
China (1) · Germany (1) · South Korea (1)
Anthony D. Ho, Ph.D., Prof. (1) · Junning Cao (1) · Won Seog Kim, MD,Ph.D. (1)